Found: 2
Select item for more details and to access through your institution.
SKIN REACTIONS ASSOCIATED WITH ORAL REVLIMID (LENALIDOMIDE) IN AL AMYLOIDOSIS (ALA); PATIENT TEACHING ENCOURAGING PROMPT REPORTING, AND CLINICAL ASSESSMENT AND MANAGEMENT OF SKIN REACTIONS CAN IMPACT PATIENT OUTCOMES.
- Published in:
- Oncology Nursing Forum, 2006, v. 33, n. 2, p. 395
- By:
- Publication type:
- Article
Kidney dysfunction during lenalidomide treatment for AL amyloidosis.
- Published in:
- Nephrology Dialysis Transplantation, 2011, v. 26, n. 3, p. 881, doi. 10.1093/ndt/gfq482
- By:
- Publication type:
- Article